Microfluidic device for optical spectroscopy

The microfluidic device with a micropillar array and immobilized whispering gallery mode microsphere resonators addresses integration challenges and detection limits by enabling capillary-driven flow and evaporation-driven sampling, facilitating rapid and sensitive pathogen detection without impractical light coupling.

WO2024243608A1PCT designated stage expired Publication Date: 2024-12-05UNIV OF SOUTH AUSTRALIA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/AU2023/050447
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-26
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current optical and fluidic phenomena in microfluidic devices are not easily integrated due to physical or chemical constraints, and existing whispering gallery mode (WGM) optical resonators have inferior detection limits when used in portable devices for pathogen detection, requiring impractical light coupling techniques.

Method used

A microfluidic device with a planar surface featuring an array of micropillars forming an open spectral region, where a whispering gallery mode microsphere resonator is immobilized between micropillars, enabling capillary-driven flow and evaporation-driven continuous sampling, and utilizing active resonators with a gain medium for enhanced sensitivity and remote excitation.

Benefits of technology

The device provides a practical and robust option for continuous monitoring of refractive index changes in liquid samples, enabling rapid and label-free detection of pathogens like influenza A virus with improved sensitivity and ease of use, avoiding the need for impractical light coupling techniques.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure AU2023050447_05122024_PF_FP_ABST
    Figure AU2023050447_05122024_PF_FP_ABST
Patent Text Reader

Abstract

A microfluidic device for an optofluidic sensor, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive an analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region, wherein the micropillars are spaced to form interpillar microchannels, there being at least one active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that analyte solution disperses about a microsphere in the spectral region and the microsphere produces a WGM modulated spectrum suitable for optical spectroscopy.
Need to check novelty before this filing date? Find Prior Art

Description

MICROFLUIDIC DEVICE FOR OPTICAL SPECTROSCOPYTECHNICAL FIELD OF THE INVENTION

[0001] The present invention relates to the use of microfluidics, and thus small volume liquid manipulation, in conjunction with advanced optical sensing for the rapid detection of analytes such as, for example, pathogens, including viruses, bacteria, fungi and parasites.BACKGROUND OF THE INVENTION

[0002] A reference to “microfluidics” is typically a reference to the use of physical structures with fluid control features having at least one dimension that is at the submillimetre level. If all or a majority of the dimensions of a physical structure are at the millimetre level, the structure would generally be referred to with the prefix milli-, while below this the physical structure would generally be referred to with the prefix nano-. Hence, throughout this specification reference will be made to microchannels and micropillars, for example, meaning generally that the channels and pillars are submillimetre in dimension. Typically, such microchannels and micropillars will actually be sized less than about 500 micrometres, or less than about 100 micrometres, but certainly greater than 1 micrometre.

[0003] Microfluidics is a multidisciplinary field at the intersection of engineering, physics, chemistry, biochemistry, nanotechnology and biotechnology, with practical applications in the design of systems in which low volumes of fluids, normally liquids, are processed to achieve multiplexing, automation, and high-throughput screening. Microfluidics emerged in the beginning of the 1980s and has been used in areas as diverse as DNA chips, lab-on-a-chip technology, micro-propulsion and micro-thermal technologies.

[0004] Conventionally, devices that manipulate liquids in the microscale offer benefits to be used as miniaturized laboratories, such as low energy consumption, shorter chemical reaction time, small sample and biological reagents consumption, low cost, high compactness, high integration and the possibility of multiple tests per device.Also, microfluidic-based devices may facilitate remote and touch-less manipulation of single cells, micro-organisms or micro-particles.

[0005] Typically in microfluidic systems, liquids are transported, mixed, separated or otherwise processed. The various applications of such systems often rely on passive liquid control using capillary forces, in the form of capillary flow modifying elements, akin to flow resistors and flow accelerators. In some applications, external actuation means are used for a directed transport of the liquid. Examples are rotary drives applying centrifugal forces for liquid transport on passive chips. Alternatively, there can be manipulation of the working liquid by active components such as pumps or valves.

[0006] Processes normally carried out in a laboratory can thus, with microfluidics, be miniaturised on a single device in order to enhance efficiency and mobility, as well as to reduce sample and reagent volumes.

[0007] Optofluidic sensor platforms are known for their unique combination of optical precision and sensitivity and lab-on-a-chip ease-of-use and efficiency. Some optofluidic sensors exploit the integration of optical components (light emitting diodes, lenses, optical filters) and microfluidics (microchannels, capillaries, droplets). However, some optical and fluidic phenomena are not easily integrated, due to incompatibility of physical or chemical constraints, and, even when achieved, tend to be anchored to the laboratory by necessary infrastructure.

[0008] Whispering gallery mode (WGM) sensing is a form of optical sensing that can be suitable for portable devices. The underlying sensing technique for this platform relies on whispering gallery mode optical resonators, which derive their “whispering gallery” name from the path that resonant light takes as it circulates in a circular cavity, similar to the one that sound waves took along the curved wall of a circular room studied by Lord Rayleigh in the early 1900’s. In these rooms, two people standing facing the wall at opposite sides of the room could hear each other even at a whisper, but would not be able to hear each other if either stepped backward toward the centre of the room. This effect was caused by the smooth, curved walls guiding the sound waves around the periphery of the room with great efficiency, while sound waves taking any other path to the listener are dissipated or scattered enroute.

[0009] WGM optical resonators are dielectric structures capable of trapping light in paths around the periphery similar to those taken by sound waves traveling from one person to another in a whispering gallery. Whispering gallery modes occur in resonators that have a circular symmetry whereby light is trapped inside by total internal reflection. The light circulates along the inner surface of the resonator, returning in phase after each round trip, hence satisfying the resonance conditions. In a WGM resonator, the spectral positions of the resonances depend not only on the resonator geometry, but also on the surrounding environment. WGMs are therefore suited for refractive index (Rl) sensing of analytes in liquid samples, and Rl sensing is an attractive sensing methodology as the Rl signal scales with the analyte concentration rather than the volume, making it suitable for small volume applications. Rl sensing is also label-free, relying on the intrinsic properties of the target species and thus requiring fewer reagents and sensing steps.

[0010] To exploit the use of WGMs, two approaches generally exist. In the most common approach, evanescent field coupling between a phase-matched optical fibre taper (or prism) and the resonator is used. While this approach has allowed for singlemolecule detection and the realisation of high Q-factors (quality-factors), the use of thin optical fibre tapers is problematic, and the use of prisms is difficult for smaller (higher- sensitivity) resonators.

[0011] The alternative approach is to use resonators with a gain medium incorporated. When such a so-called ‘active’ resonator is illuminated by a remote light source, the gain medium emits light and, due to the Purcell effect, there is an increase in the emission rate of the gain medium at the resonance wavelengths. This means that the fluorescence spectrum appears with modulated peaks corresponding to the microcavity resonances. The wavelength shifts of these resonances can then be used to infer changes in the liquid sample. However, the Q-factors for this form are typically 3 to 4 orders of magnitude lower than fibre taper or prism-coupled passive resonators, meaning that these active resonators tend to have inferior detection limits.

[0012] Before turning to a summary of the present invention, it is to be appreciated that various directional terms, such as upper, lower, upwardly, upright, bottom and the like, have been used throughout this specification to provide context and clarity for the invention with reference to the normal upright use of a microfluidic device, typically ona flat surface. These terms are not to be taken as limiting the invention to be used only in one particular orientation.

[0013] The discussion of the background to the invention herein is included to explain the context of the invention. This is not to be taken as an admission that any of the material referred to was published, known or part of the common general knowledge as at the priority date of this application.SUMMARY OF THE INVENTION

[0014] In a first aspect the present invention provides a microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive an analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that analyte solution disperses about a microsphere in the spectral region such that the microsphere produces a WGM modulated spectrum suitable for optical spectroscopy.

[0015] The present invention also provides an apparatus for optical spectroscopy, the apparatus including the microfluidic device of the first aspect, together with at least a light source and a detector such as an optical spectrometer.

[0016] Active WGM microsphere resonators immobilised within a micropillar array have been found by the inventors to be useful for label-free lab-on-chip sensing. Indeed, micropillar arrays able to utilise the feature of capillary wicking have been found to be a useful microfluidic component for handling small volumes of liquid and for then sustaining a pump-free flow through evaporation. An optofluidic sensor utilising the WGM-based device of the present invention provides a practical and robust option for continuously monitoring refractive index change in liquid samples and, with the spectral region of the device being open, quick and easy rinsing between samples is possible.

[0017] In a preferred form, the micropillars and / or the substrate are optically transparent in the spectral region. In this form, the microfluidic device is particularly suitable for transmission spectroscopy and absorbance spectroscopy.

[0018] The micropillars in the spectral region preferably project generally orthogonally from the planar upper surface of the base, where the reference to “generally” orthogonally is a reference that is intended to include normal manufacturing tolerances where there is a departure in the longitudinal axis of a micropillar from it being exactly orthogonal. The longitudinal axis of the micropillars may however be inclined.

[0019] The micropillars can be any shape in cross-section, such as square, round, elliptical, or hexagonal and the like, and may even have a cross-section that varies along the length of the micropillar, such as by having a different cross-section at the base of the micropillar than at the top of the micropillar. In a preferred form, the micropillars will be circular in cross section through their entire length, with a flat upper surface. However, the micropillars may have inclined walls so that the width at the base of a micropillar is greater than or less than the width at the top. The top of a micropillar may be tapered to a point or may expand outwardly so as to provide a ledge about the top of the micropillar, and the micropillars may have varying structures and configurations across an array, which can itself be used to create different flow patterns for the analyte solution across different arrays.

[0020] In relation to the preferred configuration of micropillars, it will be appreciated that many configurations are possible, provided that the configuration assists in ensuring that microspheres will be immobilised between micropillars within a microchannel.

[0021] The micropillar array may be an ordered array in which the dimensions of the micropillars, and hence the interpillar spacings, are substantially uniform in the array or, alternatively, the array may be a disordered array in which the dimensions are non- uniform, resulting in the interpillar spacings in the array being non-uniform.

[0022] The height of each micropillar may be from about 0.1 micrometres to about 500 micrometres, such as from about 0.1 micrometres to about 100 micrometres, or from about 1.0 micrometres to about 75 micrometres, or from about 5.0 micrometres toabout 100 micrometres, or from about 10 micrometres to about 100 micrometres, or from about 5.0 micrometres to about 50 micrometres, or from about 10 micrometres to about 50 micrometres, or from about 10 micrometres to about 30 micrometres. In specific embodiments, the height of each micropillar is about 10 micrometres. In other specific embodiments, the height of each micropillar is about 15 micrometres. In other specific embodiments, the height of each micropillar is about 20 micrometres.

[0023] Where the micropillars are circular in cross section, the diameter of each micropillar may be from about 0.1 micrometres to about 500 micrometres, such as from about 0.1 micrometres to about 100 micrometres. In specific embodiments, the diameter of each micropillar is about 10 micrometres. In other specific embodiments, the height of each micropillar is about 20 micrometres.

[0024] In certain embodiments, the microfluidic device of the present invention will be suitable for use in transmission spectroscopy and the micropillars and / or the base will be optically transparent in the spectral region so that light from a light source on one side of the microfluidic device is transmitted through the microfluidic device (and the sample) and the transmitted light is detected by a detector on another side of the microfluidic device.

[0025] In these embodiments, the microfluidic device may for example be used in an optical spectrometer with incident light directed parallel to the micropillars. In these embodiments, the optical path length may be defined by the height of the pillars in the spectral region. However, the microfluidic device of the present invention is not limited to that specific use and can also be used in reflection spectroscopy in which the light source and the detector of the spectrometer are each on the same side of the microfluidic device. In either case, the angle of incident and transmitted light may be from 0 degrees to 90 degrees. For use in optical transmission spectroscopy, the pillars do not need to be optically transparent and they can be semi-transparent or opaque but the base will usually be transparent. The incident light could also be directed orthogonally to the micropillars.

[0026] The open spectral region of the microfluidic device is an open micropillar array system where the micropillars are spaced to form interpillar microchannels where liquid can spontaneously fill into the microchannels between micropillars via a capillaryaction often called wicking, thereby forming a well-defined liquid film in the spectral region. The thickness of the liquid film is determined by the height of the pillars and the volume required to fill the spectral region is generally of the order of several microlitres.

[0027] The open micropillar array has advantages over traditional enclosed systems in terms of simple sample loading, rinsing and cleaning. Also, controllable evaporation can be used to drive a continuous flow of liquid between the micropillars subsequent to the initial capillary action that loads microchannels. Indeed, by prefilling the microchannels within the micropillar array with a known liquid, a predictable flow behaviour driven by evaporation of the liquid can then be achieved, including for a biological fluid such as saliva or sweat.

[0028] The distance between adjacent micropillars may be from about 0.1 micrometres to about 250 micrometres, which thus indicates that the microchannels may have a width also of from about 0.1 micrometres to about 250 micrometres. By holding active resonators in the form of a whispering gallery mode (WGM) microspheres in the microchannels between the micropillars, the position of a microsphere can be maintained without being influenced by the flow of liquid or being subject to random motion. Meanwhile, the evaporation-driven lateral flow of the analyte solution allows for continuous sampling and monitoring.

[0029] In relation to the use of the word “microsphere” herein, it will be appreciated that precision with respect to a shape that is perfectly geometrically spherical is not required, provided that the actual shape of the active resonator used is able to sustain a WGM profile.

[0030] In this respect, the preferred sizing of the microspheres will of course be dictated by the spacing between the micropillars and thus the width of the microchannels, meaning that the diameter of suitable microspheres will also be in the range of from about 0.1 micrometres to about 250 micrometres. For example, in one form, a square lattice of cylindrical micropillars would be provided, each micropillar having a diameter of about 10 micrometres, a height of about 20 micrometres, a diagonal spacing of about 20 micrometres and an adjacent spacing of about 10 micrometres.

[0031] In this example, a microsphere with a diameter of about 15 micrometres would be immobilised against lateral movement, centrally between four adjacent micropillars in the square lattice. Alternatively, or in addition, a microsphere with a diameter of about 10 micrometres would be immobilised against lateral movement between two adjacent micropillars. The microspheres will then ideally remain immobilised within the microfluidic device having only point contacts with the micropillars, which have been found to have only negligible impact on the microspheres’ Q-factors.

[0032] In terms of the overall number of microspheres that could be located in the micropillar array, as a single microsphere requires at least two adjacent micropillars, the micropillar array may hold (X-1) microspheres where X equals the number of micropillars in a single row. In this respect, there may be one or more microspheres in the spectral region, which will be understood to be any number between and including 1 and 10, or between and including 11 and 20, or any number between and including 21 to 100, for example.

[0033] In a preferred form, a microfluidic device in accordance with the present invention might have an overall dimension of about 7 mm by 12 mm, but the spectral region itself might only be about 6 mm by 8 mm. As mentioned above, evaporation- driven flow that is insensitive to interfacial tension and viscosity of a sample fluid can be realised in the micropillar arrays of the invention. In this respect, if the micropillar array is long enough and the spectral region is inexhausted, a continuous flow of analyte solution can be usefully achieved. To realise simple sample manipulation and create a continuous flow in the open spectral region, a longer microfluidic device, with a longer spectral region, can be adopted to allow for a previous liquid sample to be pushed further away from microspheres when a new liquid sample is added to the sample loading region, beneficially avoiding any potential mixing during the subsequent measurement. Depending upon the sample volume, the micropillar array length can be tuned from a few millimetres in length to tens of millimetres in length.

[0034] In this form, as a liquid sample evaporates, analyte concentrates towards the end of the spectral region, allowing the microfluidic device to operate over long periods before saturation of solute occurs. This does not require a previous sample to be rinsed or washed out of the device, essentially due to the longer spectral region inwhich the previous sample is pushed away towards the end of the device where it concentrates.

[0035] The spectral region of the microfluidic device may take any desired shape, such as being a square, rectangular, circular, oval and the like region. Ideally the spectral region will be rectangular or square and will include a narrowed area (such as neck) adjacent to the sample loading region or centrally across the spectral region. In this form, it may be preferred to locate microspheres at such a neck area. With this in mind, it is expected that the narrower such a neck is (at least relative to the width of a rectangular or square spectral region), the faster the flow velocity will be, as the evaporation of liquid from the relatively large spectral region area needs to be refilled from the sample loading region through the neck. Additionally, it is envisaged that a narrow neck may increase the chance of analyte interaction with microspheres.

[0036] In relation to the resonators used with the microfluidic device of the present invention, active resonators are preferred, being those with a gain medium incorporated. For example, preferred forms of WGM microspheres are doped with a fluorophore as the gain medium to enhance the resonance. In this respect, it will be understood that the word “fluorophore” refers to any molecule which exhibits the property of fluorescence and the word “fluorescence” may be defined as the property of a molecule to absorb light of a particular wavelength and re-emit light of a longer wavelength. The wavelength change relates to an energy loss that takes place in the process. The term “fluorophore” may encompass a range of optically detectable labels such as chemical fluorophores and dyes.

[0037] There are many fluorescent dyes which are available which may be used as fluorophores in accordance with the present invention. An important property of a fluorescent dye or other fluorophore, which determines its potential for use is the excitation wavelength of the fluorophore. Ideally, this will match the available wavelengths of a light source.

[0038] With this in mind, two doping techniques may be useful to form the active resonators, namely internal dyeing and external dyeing (surface-labelling). These two techniques produce particles with unique properties, each beneficial for different applications. Internal dyeing produces extremely stable particles with typically narrowfluorescence emissions. These particles often display a greater resistance to photobleaching. As the fluorophore is inside the beads, surface groups are available for use in conjugating ligands (proteins, antibodies, nucleic acids, etc.) to the surface of a microsphere, as described in relation to this second aspect of the present invention.

[0039] For this reason, internally treated microspheres are typically used in analytedetection and immunoassay applications, while the external treatment involves conjugation of the fluorophore to the microsphere surface. In this form, because the fluorophores are on the surface of the microsphere, they are able to interact with their environment just as the fluorophores on a stained cell.

[0040] With regard to a further preferred form of the first aspect of the present invention, outbreaks of various virus infections have increased the demand for lab-on- chip sensors for use at point of care (POC), with the aim of rapid, accurate, simple and cost-effective analyte detection. With this in mind, optical sensing based on the interaction between analytes and light has the advantages of easy integration with microfluidic components for sample transportation and label-free detection, especially for virus detection.

[0041] However, useful WGM sensors need to avoid impractical light coupling techniques, such as using thin optical fibres to couple light to the resonator, which is not useful for POC testing. In contrast, in the development of the present invention, the introduction of active resonance through a gain medium (such as fluorescent dyes) in microsphere resonators was recognised to advance the application of WGM sensors in POC settings, as it advantageously enables remote excitation and signal collection without a phase-matched light coupler. Thus, by exploiting the high sensitivity of WGMs, combined with the versatility of a micropillar array for fluid transfer, optofluidic sensors in accordance with the present invention have been found by the inventors to be useful for the rapid detection of pathogens, such as the influenza A virus, in liquid samples.

[0042] Therefore, in a second aspect the present invention provides a microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having:a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one functionalized active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that the functionalized active resonator binds an analyte in analyte solution dispersed about a microsphere in the spectral region, which binding is then detected using a WGM modulated spectrum and optical spectroscopy.

[0043] The present invention also provides an apparatus for optical spectroscopy, the apparatus including the microfluidic device of the second aspect, together with at least a light source and a detector such as an optical spectrometer.

[0044] In this aspect, the preferred physical features of the microfluidic device, including the microspheres, will be as described above for the first aspect.

[0045] Also in this aspect, microspheres in the spectral region, and thus in contact during use with the analyte solution, have a functional coating that is able to react, bind or release an analyte (a target species) to generate or alter an optical signal. For example, a coating comprising a biomolecule, a small molecule, a metal ion, a metal complex or the like may be formed on the surface of the microspheres and may bind a molecule or analyte of interest in the analyte solution, which binding is then qualitatively or quantitatively detected using optical spectroscopy.

[0046] For example, the microfluidic device of the present invention may thus be used to measure antibody-antigen binding where the analyte solution is suspected of containing either the antibody or the antigen. The binding can then be measured or detected by absorption, transmittance, reflection or fluorescence spectroscopy. The analyte of interest can be any atom, chemical, molecule, compound, composition or aggregate of interest for detection and / or identification, such as an amino acid, peptide, polypeptide, protein, glycoprotein, lipoprotein, nucleoside, nucleotide, oligonucleotide, nucleic acid, sugar, carbohydrate, oligosaccharide, polysaccharide, fatty acid, lipid,hormone, metabolite, cytokine, chemokine, receptor, neurotransmitter, antigen, allergen, antibody, substrate, metabolite, cofactor, inhibitor, drug, pharmaceutical, nutrient, prion, toxin, poison, explosive, pesticide, chemical warfare agent, biohazardous agent, radioisotope, vitamin, heterocyclic aromatic compound, carcinogen, mutagen, narcotic, amphetamine, barbiturate, hallucinogen, waste product and / or contaminant.

[0047] There is a range of biomolecules that may be utilised as binding sites for the selective binding of a desired bioanalyte from a biological sample. For instance, such biomolecules may include proteins, nucleic acids, peptides, lipo- peptides, proteinbinding carbohydrates or protein-binding ligands.

[0048] In one embodiment, the biomolecule is a nucleic acid or a capture protein. Nucleic acids include DNAs and RNAs and may be single stranded or double strander. In preferred embodiments, the nucleic acid is single stranded.

[0049] Suitably, the capture protein may be a protein-binding scaffold, streptavidin, a T-cell receptor, a binding-fragment of a TCR, a variable lymphocyte receptor, an antibody and / or a binding-fragment of an antibody. The binding-fragment of an antibody may include a Fab, (Fab’)2, Fab’, single-chain variable fragment (scFv), di- and tri- scFvs, single domain antibodies (sdAb), Diabodies or a fusion protein including a binding-domain of an antibody

[0050] Protein binding scaffolds have emerged as viable molecules for binding with a diverse range of bioanalytes including proteins. Protein binding scaffolds typically comprise a stable protein structure (scaffold) which can tolerate modification of amino acids within designated binding regions without alteration of the relative arrangement of the binding domains. These protein-binding scaffolds include (but are not limited to): Adnectins, Affilins (Nanofitins), Affibodies, Affimer molecules, Affitins, Alphabodies, Aptamers, Anticalins, Armadillo repeat protein-based scaffolds, Avimers, Designed Ankyrin Repeat Proteins (DARPins), Fynomers, Inhibitor Cystine Knot (ICK) scaffolds, Kunitz Domain peptides, Monobodies (AdNectins™) and Nanofitins.

[0051] The coating can be formed on microspheres by any suitable method, such as physical adsorption, self-assembly, chemical reaction on the surface from solutionor vapour, plasma deposition, atomic layer deposition, electrostatic adsorption, and the like. For example, a quartz substrate can be chemically modified by silanization using an alkylsilane in which the tail of the silane contains the appropriate chemical / biological functionality.

[0052] In an embodiment, the operation of an optofluidic sensor using the microfluidic device of the present invention utilises, as mentioned above, the evaporation-driven flow enabled by the micropillar array. This evaporation-driven flow continuously carries the analyte-containing sample through to interact with, in a preferred form, an active biofunctionalised microsphere. When the analyte (such as a Flu-A virus, whole or fragmented) flows past a biofunctionalised microsphere (for example, functionalised with a virus specific antibody) and binds onto it, a change on the surface of the microsphere can be detected. In particular, peaks of a WGM modulated fluorescence spectrum will show shifts towards longer wavelengths. With further analytes captured by the coated microsphere, the shift will become larger until all binding sites on the single microsphere are saturated. The amount of the shift corresponding to the amount of the analyte binding events can then be used for quantitative analysis.

[0053] In a preferred form of the first and second aspects of the present invention, one or more micropillars may be surface modified to increase the detection sensitivity of apparatus incorporating the microfluidic device of the present invention, such as by creating predetermined liquid flow patterns through the spectral region or by reducing interference by undesired chemicals in the analyte solution . In this form, the surface modification can occur during the formation of the micropillars, so that the micropillars are directly formed with such surface modifications, or the surface modifications can occur as a secondary step after the formation of the micropillars.

[0054] Therefore, in a third aspect the present invention provides a microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; andb) a sample loading region configured to receive an analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that analyte solution disperses about a microsphere in the spectral region and the microsphere produces a WGM modulated spectrum suitable for optical spectroscopy; and wherein one or more micropillars are surface modified in the spectral region to increase detection sensitivity.

[0055] The present invention also provides an apparatus for optical spectroscopy, the apparatus including the microfluidic device of the third aspect, together with at least a light source and a detector such as an optical spectrometer.

[0056] In this aspect, the preferred physical features of the microfluidic device, including of the microspheres, will be as described above for the first aspect.

[0057] The surface modification of micropillars may be any suitable form of modification that assists with increasing detection sensitivity, ideally by way of assisting to reduce the sample matrix effect. For example, micropillars in the spectral region could be modified with charged molecules. The micropillars with charges will assist with flow, but at the same time may preferably adsorb any undesired chemicals or molecules in the analyte solution that show opposite charges, which can potentially reduce the interference from those undesired chemicals for detection.

[0058] In another form, surface modification can be the creation of predetermined liquid flow patterns for the analyte solution through the spectral region to increase detection sensitivity.

[0059] For example, masks may be applied to micropillars during or after fabrication of the microfluidic device for chemical patterning, such as by applying masks with predetermined patterns onto surfaces of hydrophobised micropillars before exposing the micropillars to oxygen plasma. In this form, micropillar areas without masking become hydrophilic again, whereas areas under the mask are protected from plasmatreatment and remain hydrophobic. By modifying some micropillars in this manner, but not others, or by modifying a portion of a micropillar but not the entire micropillar, a preferred flow path can be created through the micropillar array to increase or improve contact with one or more microspheres in certain positions in the spectral region.

[0060] It is envisaged that creating flow patterns in the micropillar array is likely, at least in the biofunctionalized form of the invention, to assist enrich the viral protein and increase detection efficiency. Furthermore, and also at least in the biofunctionalized form, such flow patterns may change the evaporation profile of the liquid inside the micropillar array, thus altering the interaction between antibodies and viruses.

[0061] In addition, the creation of flow patterns can create several independent micropillar arrays in parallel with each other within one microfluidic device, with each array ideally sharing the same sample loading region. However, each array may be used to immobilise microspheres with different functionalisation for targeting different analytes. In this embodiment, multiplex detection can be achieved within a single microfluidic device.

[0062] Finally, for a specific flow pattern, a micropillar array may be fabricated directly to reflect the flow pattern, meaning that micropillars will only be present in a pre-determined flow area. If a micropillar array is fabricated through photolithography and etching, a photomask can be designed according to the flow pattern. If a micropillar array is fabricated by other methods, such as 3D printing, micropillars will likely only be printed in a specific flow area.

[0063] Also then, in a fourth aspect the present invention provides a microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one functionalized active resonator, in the form of a whispering gallerymode (WGM) microsphere, immobilised between micropillars within a microchannel, such that the functionalized active resonator binds an analyte in analyte solution dispersed about a microsphere in the spectral region, which binding is then detected using a WGM modulated spectrum and optical spectroscopy; and wherein one or more micropillars are surface modified to increase detection sensitivity.

[0064] The present invention also provides an apparatus for optical spectroscopy, the apparatus including the microfluidic device of the fourth aspect, together with at least a light source and a detector such as an optical spectrometer.

[0065] In this aspect, the preferred physical features of the microfluidic device, including of the microspheres, will be as described above for the first aspect.

[0066] Additionally, in this aspect the preferred forms of functionalisation of the microspheres and of surface modification of the micropillars will be as described above for the third aspect.

[0067] In a fifth aspect the present invention provides an optical spectroscopic method of detecting an analyte in a liquid sample, the method including: a) providing a microfluidic device according to any one of the first to fourth aspects described above; b) placing a liquid sample of an analyte solution in the sample loading region of the microfluidic device such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region to provide a liquid filled spectral region; c) exposing a first side of the microfluidic device to a light source such that an incident light beam is projected through the liquid in the spectral region to a detector located at a second side of the spectral region that is opposite the first side, or exposing a first side of the microfluidic device to a light source such that an incident light beam passes through the liquid in the spectral region and is reflected from the base of the microfluidic device to a detector located at the first side of the microfluidic device; and d) measuring at least one parameter of the light at the detector in an optical spectrometer to detect the analyte in the sample.

[0068] In this optical spectroscopic method, the analyte may be a bioanalyte and the liquid sample may include a biological sample from a subject. The bioanalyte may be a virus, a protein, a peptide, a nucleic acid, a carbohydrate, a lipo-peptide, a hormone, bacterium, a fungus, a prion, or a fragment of any of the above.

[0069] The microfluidic devices described herein can be used for any form of optical spectroscopy, including "reflectivity", "absorbance", "transmission", and "fluorescence" spectroscopy. For ease of description, further reference will be made to the use of the microfluidic devices in UV and visible (UV-Vis) spectroscopy. However, it will be appreciated that the microfluidic devices of the present invention are not limited to that particular spectroscopic use and they can equally be used in other spectroscopic techniques.

[0070] Additionally, the micropillar array can be formed by any suitable means, including by forming a template on the planar upper surface of the base of the microfluidic device to provide a templated base, etching the templated base under conditions to form an array of pillars extending from the planar upper surface of the base, with each micropillar in the array ideally being of substantially equal height. With this in mind, the templated base can be formed by coating at least a portion of the planar upper surface of the base with a photoresist layer, and exposing the photoresist layer to UV radiation through a patterned photomask to form a patterned template on the planar upper surface of the base. Micropillar arrays could also be directly stamped or moulded into the base of a microfluidic device, or a photoresist could be directly used as the micropillars.

[0071] The base and micropillars of the microfluidic device can also be formed from any suitable material. For use in optical transmission spectroscopy, the micropillars can be optically transparent, semi-transparent or opaque and the base will usually be transparent. Transparent micropillars and / or bases can be formed from an optically transparent material and suitable materials for this purpose include plastics such as Thermanox™ vinyl and cellulose acetate or glasses such as borosilicate glass, fused silica, quartz, soda lime, and silicate glass. Alternatively, the base could be chosen to reflect incident light back to a detector that is located on the same side of the microfluidic device as the light source. In these cases, the base may be any reflectivematerial, such as a silicon wafer, metal or metal-coated polymer or glass, or other material with a reflective coating.

[0072] For opaque micropillars, an optically transparent base including plastics such as Thermanox™ vinyl and cellulose acetate or glasses such as borosilicate glass, fused silica, quartz, soda lime, and silicate glass can be first coated with a thick layer of an opaque material and the micropillars then formed by etching. Suitable opaque materials include any opaque metal, such as Cr, Pt, Au, Ti, Ti20 , Ag and / or Cu that can be sputter coated onto the base. An opaque polymer that can be sputtered could be used. Alternatively, still, the micropillars could be painted or stamped with any opaque paint or ink.BRIEF DESCRIPTION OF THE FIGURES

[0073] The present invention will now be described with reference to various figures, graphs and tables. However, the following description is not to limit the generality of the above description.

[0074] In the figures:

[0075] Figure 1 (a) is a schematic of a microfluidic device (not to scale) of a first embodiment with immobilised whispering gallery mode microspheres incorporated, and Figures 1 (b) and 1 (c) are SEM micrographs of the polystyrene microspheres immobilised within the open microfluidic device;

[0076] Figure 2 shows an experimental setup using an inverted microscope for interrogation of whispering gallery microspheres integrated into the open microfluidic device;

[0077] Figure 3(a) shows a typical normalized WGM-modulated fluorescence spectrum (blue: pure water, or-ange: 0.25 g / mL glucose in water) of 15 pm microspheres (FSR ~ 4.8 nm) lodged in an open microfluidic device; Figure 3(b) shows the wavelength shift of isolated TE and TM resonances from grey-dashed box in Figure 3(a); and Figure 3(c) shows the wavelength shift of TE and TM modes within the microfluidic chip as a function of refractive index;

[0078] Figure 4 shows the wavelength shift of TE and TM WGMs within a longer microfluidic device, as a function of glucose concentration;

[0079] Figure 5 shows in-device dynamics monitored for the microfluidic device pre- loaded with water, as a 5 pL droplet of 0.25 g / mL glucose was added to the sample loading region;

[0080] Figure 6 shows cycling tests between water and Figure 6(a) 0.15 g / mL or Figure 6(b) 0.25 g / mL glucose solutions in the device;

[0081] Figure 7 is a visual demonstration of the behaviour of the microfluidic system (the 7 mm x 12 mm device) using Ponceau-4R colour dye;

[0082] Figure 8 is a schematic of an optofluidic sensor of a second embodiment based on active WGM microsphere resonators for virus detection;

[0083] Figure 9(a) is a top-view of the quartz micropillar array and its pillar structure; Figure 9(b) are CAD designs of a micropillar array and a mask for chemical patterning; Figure 9(c) shows a variety of chemical patterning masks printed with a cutting machine; and Figure 9(d) shows two different surface chemistries achieved on the micropillar array after chemical patterning;

[0084] Figure 10(a) shows scanning electron micrographs of the WGM microspheres trapped between two micropillars; Figure 10(b) is a schematic of the optical measurement from a WGM microsphere trapped in a micropillar array;

[0085] Figure 11 (a) is a demonstration of the evaporation-driven flow on a micropillar array; Figure 11 (b) shows viruses captured by the microsphere via antibodyantigen binding; and Figure 11(c) is the WGM spectra of the microsphere over time to show the simultaneous virus binding-induced change;

[0086] Figure 12(a) is the WGM spectra of the Flu A antibody-coated microsphere after interaction of Flu A virus; Figure 12(b) shows the peak shift as a function of on- device interaction time;

[0087] Figure 13 shows high-resolution N 1s XPS spectra of Figure 13(a) a quartz micropillar array, Figure 13(b) the Nile red doped polystyrene microsphere on themicropillar array, Figure 13(c) the antibody-coated microsphere on the micropillar array and Figure 13(d) the antibody-coated microsphere on the micropillar array after virus detection, with the inset in Figure 13(b) showing the chemical structure of Nile red;

[0088] Figure 14(a) shows three patterned and an unpatterned micropillar array after virus detection experiments; and Figure 14(b) shows the optical shifts of the antiFlu A coated microspheres on the four different patterned / unpatterned arrays against the interaction time with Flu A Victoria virus solution.DETAILED DESCRIPTION OF EXPERIMENTAL WORK1. Experimental Setup1.1 Active WGM Microspheres

[0089] Polystyrene microspheres (Polysciences Inc., USA) with nominal diameter of 15.0 pm, standard deviation of 0.6 pm, and refractive index of 1.591 were used. The fluorescent dye incorporated in the microspheres was Nile Red (Sigma Aldrich, Aabs ~ 532 nm, Aem ~ 590 nm) using a two-phase technique. In this technique, the Nile Red is dissolved in xylene up to the solubility limit. The solution is then poured into an aqueous solution of microspheres and stirred with a magnetic stirrer until the xylene has evaporated. Since xylene and water are immiscible and the fluorescent laser due is hydrophobic, the fluorescent dye is transferred into the microspheres on contact when the xylene evaporates. After the microspheres are doped, the solution is heated at 95°C for 1 hour to remove the solvent. The microspheres are then washed by centrifugation, and the supernatant removed.1.2 Microfluidic Device Fabrication with Open Spectral Region

[0090] Microfluidic devices were fabricated in fused silica using standard photolithography and plasma etching techniques.

[0091] A 6-inch diameter fused silica wafer (Shin-Etsu Quartz Products Co., Ltd.) was first deposited with 100 nm of Cr via sputtering (HHV TF500) which serves to stop glass reflection of UV light during the photolithography process. It was then spin coated with SU8-10 photoresist at 2500 rpm for 30 seconds. After pre-exposure baking at 65°C for 2 min and 95°C for 5 min, the SU8 photoresist layer on the silica wafer was exposedto UV (360 nm, EVG 620) at a dose of 150 mJ / cm2through a chromium-glass photomask of circular patterns in hard contact mode.

[0092] Post-exposure baking was conducted at 65°C for 1 min and 95°C for 2 min and the SU8 patterns on the wafer were developed in propylene glycol monomethyl ether acetate for 2 min, prior to hard baking at 130°C for 10 min. Plasma etching (LILVAC, NLD570) based on Ar and C3F8 gases was carried out on the SU8-patterned wafer to sequentially remove the exposed Cr and etch the silica to a required depth. The remaining Cron the silica wafer was removed by 10% (w / v) ceric ammonium nitrate solution, rendering totally transparent open microfluidic device.

[0093] This microfluidic device has a square lattice of micropillars with a diameter of 10 pm, a height of 20 pm and lattice spacing of 10 pm. The spectral region (ie, the analysis area) of the device (itself 7 mm x 12 mm) is approximately 6 mm x 8 mm.

[0094] The integration of the microspheres into the spectral region of the device was realised via the following steps.

[0095] A 3 pL droplet of diluted microsphere solution was first loaded into the middle of the array using a pipette and allowed to diffuse through the micropillars. A brief torrent from an ultra-high purity nitrogen flow from a handheld gun was used to dry the spectral region. The microspheres (typically about 10 within the micropillar array) remained firmly lodged within the microfluidic device with only point contacts with the micropillars that were found to have negligible impact on the microspheres’ Q-factors. The microfluidic device was optimized such that the pitch of the micropillars was ideal for capturing the microspheres. This removed the challenge of tracking microspheres which otherwise would be perturbed by liquid flowing over them.

[0096] A schematic of the open microfluidic deivce (not to scale) is shown in Fig. 1(a) with SEM micrographs (Zeiss Merlin Field-Emission Gun SEM) of microspheres immobolised between micropillars shown in Figure 1 (b) and Figure 1 (c).1.3 Interrogation Setup

[0097] A 532 nm CW laser source (JDS Uniphase, Model 21006959) was coupled into the back port of an inverted microscope (IX 71 , Olympus, Japan) equipped with a532 nm dichroic filter effectively using the microscope in a confocal arrangement. The free-space excitation of the microspheres in the microfluidic device was achieved through the inverted microscope with a 20* objective, using the 532 nm laser as the pump source. The focal length of the objective is -3 mm. The emission was collected back through the same objective and coupled into a 200 pm patch fiber. A non-planar configuration with perpendicular orientation of the incoming and outgoing light was used, but it would be possible to integrate optical waveguides and LED sources into the base of the device to realise a planar device.

[0098] The WGM modulated fluorescence spectrum from a given microsphere was then spectrally resolved by a monochromator (iHR550, Horiba, Japan) equipped with a 1200 lines / mm, 500 nm blaze grating and a thermoelectrically-cooled CCD (Synapse 2048 pixels, Horiba, Japan). The experimental setup is shown in Figure 2. A series of glucose solutions ranging in concentration from 0.05 g / mL to 0.3 g / mL was then prepared (uncertainty of < 5%). Glucose was chosen since the refractive index is well known and linear with respect to the concentration making it ideal for characterizing the resonance shift as a function of refractive index.1.4 Results and Discussion

[0099] The sensing principle of this optofluidic sensor was demonstrated with a series of glucose solutions. In the first series of tests a new microfluidic device and microsphere was used for each individual glucose concentration measurement.

[0100] To optically characterise this integrated WGM microsphere-based sensor, purified water (3 pL) was first loaded into the sample loading region of the device and allowed to wick across the surface of the spectral region (6 mm x 8 mm) by capillary action. A microsphere with suitably high-quality WGMs was then located and the spectrum was recorded under 532 nm laser excitation of -200 pW. The water in the microfluidic device was then left to evaporate, before a given concentration solution of glucose (3 pL) was loaded into the sample loading region. With the microsphere immersed in the solution the spectrum was recorded for the given glucose concentration and the shift of the resonance peaks towards longer wavelengths (i.e. red shift) compared to pure water was determined (Figures 3(a) and 3(b)). This process was then repeated for each of the remaining glucose concentrations, using newmicrofluidic devices and new microspheres for each measurement, avoiding the requirement for rinsing. A total of three measurements were taken and averaged for each glucose concentration.

[0101] Within the timeframe of the measurements undertaken and at -200 pW no significant photobleaching of the Nile Red dye in the microspheres was observed. Predominantly the first-order Transverse Electric (TE) and Transverse Magnetic (TM) polarisation whispering gallery modes are observed for the resonator in aqueous solution, although higher-order modes with lower intensity and lower Q-factor (A / AF HM) appear to be present as seen in the spectrum of Figure 3(a). The resonance wavelength positions were determined using Lorentz fits on the resonance peaks. Typical Q-factors of around 5 x 103were calculated for the first-order TE and TM modes (AF HM - 120 pm at 600 nm), which is comparable with previous findings.

[0102] The resonance wavelength shift at - 600 nm for the TE and TM modes relative to pure water for each of the individual glucose concentrations (average of three measurements, error given as S.D.) was plotted against the refractive index of the glucose solution, as shown in Figure 3c. The response is clearly linear in the range considered as is expected since the relative change in refractive index is approximately equal to the relative change in resonance wavelength, i.e. bn / n = <5A / A. The TM polarisation has higher sensitivity as might be expected due to the associated weaker confinement of light within the resonator and hence stronger evanescent field. The refractive index sensitivities of the TE and TM modes are 31 ± 3 nrn / RIU and 40 ± 3 nrn / RIU, respectively, and this is comparable with values previously reported. The redshift in the resonances occurs due to a decrease in the confinement of light in the microspheres as the index contrast decreases. This in turn results in an increase in the optical pathlength (i.e. longer wavelength) necessary to satisfy resonance.

[0103] The detection limit (LoD) was calculated based on the more sensitive TM modes which had a sensitivity of 39.6 ± 2.5 nrn / RIU. Wavelength shifts in the resonance peaks equivalent to one full-width half-maximum (FWHM) can readily be determined using Lorentz fits and this was used as the basis to determine the LoD. The FWHM from the definition of Q-factor is given by:

[0104] The LoD can then be given as:

[0105] When using the lower limit of the refractive index sensitivity (i.e. 37.1 nrn / RIU) and given the Q-factor of the WGM modes was typically ~5 x 103at 600 nm, this leads to an LoD of 3 x 1O-3Rill (~20 mg / mL glucose). Improvement of the Q-factor using lasing or by using higher quality microspheres could see detection limits further enhanced to around 10'4Rill, an upper limit imposed by the 4 pm resolution limit when using the 2400 lines / mm grating of the monochromator. The variability observed in the refractive index sensitivity can be accounted for by the use of different-size microspheres (15.0 pm ± 0.6 pm) for different glucose measurements. The wavelength Free Spectral Range (AAFSR) was used to confirm that the diameters of the microspheres were within the standard deviation prescribed by the manufacturer using:where A = 600 nm is the fluorescence wavelength, n = 1.59 is the refractive index of the microsphere at A and R is the microsphere radius. Along with the red-shift of the resonances with increasing glucose concentration we also observed a reduction in Q- factor. This results because of a decrease in WGM confinement and increase in evanescent field when the refractive index contrast between the microsphere and its surrounding decreases. The trend was approximately a reduction in Q-factor of ~200- 300 per 0.01 Rill change

[0106] In the second series of tests, a microfluidic device preloaded with water was used for the glucose measurements in an attempt to further understand the behaviourof the microfluidic system. In these tests the liquid in the analysis area was not allowed to evaporate before adding the next glucose concentration to the reservoir. This serves to simulate repeated use of the microfluidic system and assists in understanding the platform’s behaviour as relevant to continuous real-time Rl measurements. A single microfluidic device and microsphere was thus used for all glucose concentrations.

[0107] Evaporation-driven flow that is insensitive to interfacial tension and viscosity of a sample fluid can be realised in the micropillar arrays used in the present invention. If the micropillar array is long enough and the reservoir is inexhausted, a continuous flow can be achieved. To realise simple sample manipulation and create a continuous flow in the open microfluidic device, a longer microfluidic device with a 15 mm wide x 70 mm long array of micropillars was used for these glucose measurements. The longer device allows for the previous liquid sample to be pushed further away from the WGM microsphere when a new liquid is added to the sample loading region avoiding any potential mixing during the measurement. As the water evaporates, the glucose concentrates towards the end of the array, allowing the device to operate over long periods before saturation of solute occurs.

[0108] In these tests a new microsphere-laced device was loaded with 10 pL of purified water through its sample loading region, and a single high-quality WGM microsphere was located, typically around 30 mm down the device. This was followed by applying a 7 pL droplet of the 0.05 g / mL glucose solution to the sample loading region with a pipette, when the preloaded water in the sample loading region had evaporated (approximately 1-2 minutes) but the spectral region was still wet. The spectrum of the microsphere was then measured within a few seconds. The fluid in the sample loading region driven by evaporation was allowed to completely flow into the micropillar array over approximately 1-2 minutes and then, while the spectral region was still wet, 7 pL of the 0.10 g / mL glucose solution was applied.

[0109] Immediately the spectrum of the microsphere was recorded again. This process was then repeated for the higher concentrations, ensuring at each step that the sample loading region had expired to avoid mixing or dilution of the analyte solutions. This approach differs to the previous methodology in that it uses the same microspheres and device for all measurements and may be suitable for continuous measurements. It also does not require the previous sample to be rinsed or washedout of the device. Both advantages come from having the longer device, in which the previous liquid is pushed away towards the end of the device where it concentrates.

[0110] The resonance wavelength shift for the TE and TM modes at around ~ 600 nm as a function of the glucose concentration is shown in Figure 4. The response observed is again linear with higher sensitivity for the TM modes as expected. The gradients of the linear fits differ from the previous set of results from Figure 3(c) by up to 25 % because the location of the microsphere with respect to the reservoir differed. Since there is an approximately exponential increase in glucose concentration along the device length, this means that the position of the microsphere along the device can be important for calibration purposes and can influence the sensitivity of the device. The longer pillar array has the advantage of the previous glucose solution being transported far from the microsphere location (i.e. to the end of the longer micropillar array), which ensures that the next measurement is not affected by the previous measurement. This allows the microfluidic device of this embodiment to be used repeatedly or continuously.

[0111] The in-device fluid dynamics are analysed in Figure 5. This figure shows a times series of the in-device glucose concentration determined from the wavelength shift of, in this case, a TM mode resonance at ~ 600 nm, as a 5 pL 0.25 g / mL concentration glucose droplet was added to the water-loaded device. In this time series, measurements were taken at 6.5 second intervals over 115 seconds, with the result clearly showing a ‘front’ of high-concentration glucose flowing across the WGM microsphere. The shift in resonance peak is reversible when pure water is again added into the sample loading region.

[0112] In Figure 5 the response time is ~ 15 seconds. However, the sensor’s response time can be shortened by reducing the distance between the microsphere and the sample loading region or by enhancing the evaporation rate. Figure 5 therefore demonstrates the power of the whispering gallery mode microspheres for characterising not only the behaviour and fluid dynamics of the open microfluidic device but also for potential real-time or continuous analysis of sample concentrations, without mechanical pumps, and that could be implemented without bulk components.

[0113] There exists the possibility of slowly flowing liquid into the sample loading region of the device with auxiliary microfluidic channels and undertaking real-time continuous monitoring of the concentration of a given liquid. This is possible because the whispering gallery mode resonance shift is reversible as shown above. Thus, cycling tests were undertaken where the concentration of glucose is increased and decreased multiple times in the device with specific concentrations fed to the sample loading region via a pipette.

[0114] First the spectrum of a microsphere located in a water-loaded microfluidic device (the longer device with the 15 mm x 70 mm spectral region) was recorded. A 7 pL droplet of the glucose solution was then added to the sample loading region in the same manner as described above and the spectrum was measured. This was followed by applying a 10 pL droplet of water to the sample loading region after 1 minute and then re-measuring the spectrum. The resonance shifts of 3-repeats of the water- glucose cycles are shown in Figure 6 for the case of glucose concentrations of Figure 6(a) 0.15 g / mL and Figure 6(b) 0.25 g / mL. These results show that the resonance wavelength shift is reversible and repeatable. This occurs because the liquid added into the sample loading region eventually pushes the previous liquid or glucose solution towards the end of the microfluidic device which is seen as a deposited high- concentration band. The behaviour of the open microfluidic system that enables continuous sampling can also be visualized using color dye instead of the transparent glucose solution.

[0115] Figure 7 demonstrates the capillary and washing cycles and as is expected the dye is pushed towards the end of the device where it concentrates when the droplet of water is added. This permits continuous sampling with the new liquid sample flushing out the previous. These results further demonstrate that real-time monitoring of liquids should be possible using the microfluidic device of the present invention. The elimination of the requirement for mechanical pumping, and the longer time-scales for evaporative flow (up to 10 seconds), could thus allow for extended monitoring of environmental or biological samples in a compact device. The microfluidic approach can be used for sensing that is independent of temperature and humidity and, as will be exemplified below, the bioconjugation of the microspheres would be expected toallow for specific binding of a variety of target analytes including proteins, bacteria and DNA.

[0116] The exemplification in this embodiment shows a practical integrated optofluidic platform that could be suitable for whispering gallery mode biosensing. The platform uses evaporation-driven microfluidic devices to deliver liquid to active microsphere resonator sensors. The preferred use of active resonators having a gainmedium incorporated avoids the use of cumbersome optical fiber tapers and allows for free-space excitation and illumination of the whispering gallery modes. The in-device behaviour shows that real-time monitoring of liquid flow should be possible using this platform, because the refractive index of a liquid can be measured continuously (increase and decrease in the refractive index).2. Experimental Setup2.1 Materials

[0117] Antibodies. The immunoglobulin fraction of rabbit anti-Flu A polyclonal antibody was used to coat WGM microspheres in carbonate / bicarbonate buffer pH 9.6. The Flu A specific antisera were prepared in a normal manner.

[0118] Influenza A and B viruses (Flu A / Fu B). Three subtypes of p-propiolactone- inactivated Flu A vaccines were tested. The subtypes were A / South Australia, A / Victoria and B / Victoria. - The inactivated Flu A and B viruses were provided by the WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia. The viral protein concentrations were ca. 2-3 mg / mL.

[0119] PBS buffer (pH 7.4) was purchased from Lonza Bioscience. Carbonate / bicarbonate buffer (pH 9.6) was prepared with 0.0875M sodium carbonate and 0.0125M sodium bicarbonate in MilliQ water. A blocking buffer was prepared with 2% (w / v) skim milk powder dissolved in PBS containing 0.05% (v / v) Tween 20 (Sigma Aldrich).2.2 Fabrication of Quartz Micropillar Arrays with Surface Modification

[0120] The quartz micropillar arrays are comprised of 10 pm diameter, 20 pm height cylindrical pillars with a lattice spacing of 20 pm (Figure 2a). They were fabricated bySU8 photolithography and plasma etching process at the South Australian Node of Australian National Fabrication Facility.

[0121] The quartz micropillar arrays were first treated with piranha solution (a mixture of 98% (v / v) sulfuric acid and 30% (v / v) hydrogen peroxide in a volumetric ratio of 3 to 1) for at least an hour to create hydroxide groups on the quartz surfaces. The array samples were then placed in a desiccator together with 1 mL of trichloromethylsilane (TCMS, Sigma-Aldrich) for an hour. The easily vaporised TCMS would react with hydroxide groups to form a hydrophobic organic layer on the quartz.

[0122] A variety of masks for surface modification via chemical patterning (Figure 2b and 2c) were printed with a cutting machine (Silver Bullet Cutter) on self-adhesive tapes. Those adhesive masks were stuck on the top of the hydrophobised micropillar arrays before being exposed to oxygen plasma for 1 min. The micropillar areas without masking became hydrophilic again, whereas the areas under the mask were protected from plasma treatment and remained hydrophobic (Figure 2d).2.3 Preparation of WGM Microspheres

[0123] The WGM microspheres were doped with fluorescent dyes as the gain medium to enhance the resonance. The doping process is, briefly, polystyrene microspheres (Polysciences Inc.) with a diameter of 10-15 pm in aqueous solution were mixed with xylene containing Nile red (Sigma Aldrich, Aabs ~ 532 nm, Aem ~ 590 nm). The mixture was stirred to evaporate the organic solvent, xylene. The organic dye, Nile red, then entered the polystyrene microspheres to complete the doping. The doped polystyrene microspheres were suspended in an aqueous solution and stored at 4 °C before use.2.4 Biofunctionalisation of the WGM Microspheres

[0124] The polystyrene microspheres were incubated with antibody (1 : 100, v / v) in pH 9.6 carbonate buffer at 4°C overnight in an Eppendorf tube. The microspheres were pelleted in a microcentrifuge at 1000 G for 5 min. The solution was carefully removed before a blocking reagent, i.e., 2% (w / v) skim milk in PBS buffer containing 0.05% Tween 20 (Sigma-Aldrich), was added into the Eppendorf tube and incubated for 30min at room temperature (~23°C). The antibody-coated microspheres were then washed three times with PBS buffer and stored in PBS for further use.2.4 Virus Detection

[0125] The antibody-coated WGM microspheres were directly loaded onto the micropillar arrays by pipetting microsphere suspension onto the micropillar array and carefully drying them under a nitrogen stream. Due to the size limitation, the microspheres were trapped firmly between pillars and immobilised, as shown in Figure 10a. The fluorescent spectrum of the microsphere was obtained with the setup shown in Figure 10(b) where a 532 nm CW laser was used to excite the antibody-coated WGM microsphere in the micropillar array through a 20 x objective. The emission light from the microsphere was collected with a monochromator (iHR550, Horiba, Kyoto, Japan) equipped with 600 lines / mm, 500 nm blaze grating and a thermoelectrically cooled CCD (Synapse 2048 pixels, Horiba, Kyoto, Japan).

[0126] For virus detection experiments, a microsphere located in the middle of the micropillar array was usually chosen. PBS buffer was first introduced into the micropillar array through the sample loading region to rehydrate the microsphere and establish a signal baseline. Once the PBS solution in the sample loading region exhausted, 2.5 pL of a virus sample solution was immediately added to the sample loading region. Driven by the evaporation of liquid from the micropillar array, the virus solution moved into the micropillar array and replaced the previous PBS solution to interact with the antibody- coated microsphere. Whenever the solution in the sample loading region ran low, more sample solution was added till the end of the measurement. During this time, the spectra of the WGM microsphere were recorded every few minutes to monitor the change in the microsphere due to virus interaction.2.4 Characterisation of the Sensing Platform

[0127] The profiles of the micropillar array and microspheres were imaged with a Zeiss Crossbeam 540 scanning electron microscope (SEM). The biofunctionalisation of the microspheres was characterised by Kratos X-ray photoelectron spectroscopy. C 1s, N 1s and Si 2p signals were analysed to obtain the surface information.2.5 Results and Discussion

[0128] The operation of the optofluidic sensor depends on an evaporation-driven flow enabled by the micropillar array. As shown in Figure 11a, the evaporation-driven flow continuously carries the analyte-containing sample through to interact with the biofunctionalised microsphere. When the analyte flows past the specifically coated microsphere and binds onto it as shown in Figure 4b, the change on the surface of the microsphere will be detected. As indicated in Figure 4c, the peaks of the WGM fluorescence spectrum will show shifts towards longer wavelengths. With further analytes captured by the coated microsphere, the shift will become larger until all of the binding sites on the single microsphere are saturated. The amount of the shift corresponding to the amount of the analyte binding events can be used for quantitative analysis.

[0129] To demonstrate the performance of the optofluidic sensor, a sample of Flu A virus (AA / ictoria) was tested against the anti-Flu A antibody-coated microsphere. Figure 12 shows a consistent optical shift after Flu A virus interaction with the microsphere, suggesting the binding of Flu A viruses with the antibodies on the microsphere. The total volume of Flu A Victoria used was 10 pL over a period of 25- minute measurement, which highlight the benefit of this optofluidic sensor for handling the extremely small volume of sample solution. A separate control experiment was also performed to confirm the specificity of the binding. Instead of using Flu A virus, a sample of Flu B virus (B / Victoria) that should not have any affinity with the anti-Flu A antibody was added to the sample loading region to perform the same sensing experiment. As shown in Figure 12(b), there is no detectable optical shift after the Flu B virus solution flowed through the sensor for 20 min, confirming the binding specificity.

[0130] To further confirm the specific binding between virus and the antibody- coated microsphere, surface analysis was performed on the microspheres before and after the virus detection experiment by X ray photoelectron spectroscopy (XPS). Figure 13 displays the N 1s XPS spectra among four different surfaces, namely, untreated quartz micropillar array, Nile red doped WGM polystyrene microsphere on the micropillar array, antibody-coated WGM microsphere on the micropillar array (i.e. , the optofluidic sensor before virus detection) and virus-bound microsphere on the micropillar array (i.e., the sensor after virus detection).

[0131] As expected, no nitrogen was detected from the untreated micropillar array (Figure 13(a)). Two nitrogen peaks identified in Figure 13(b) at 401. 4 eV and 399.9 eV can be assigned to the two nitrogen species in Nile red, one from the phenoxazine core and the other in the tertiary amine group, respectively. An increase of the N 1s peak at 399.9 eV was observed from both the antibody-coated microsphere surface (Figure 13(c)) and the surface after virus detection (Figure 13(d)). The peak at 399.9 eV is attributed to the nitrogen in amide or amine groups from proteins, which confirms the presence of antibody coating on the microsphere. Furthermore, the ratio between the two peaks at 399.9 eV and 401.4 eV is 1 :1 for bare WGM microsphere (Figure 13(b)), 3:1 for antibody-coated microsphere (Figure 13(b)) and 9:1 for virus-bound microsphere. The increasing N 1s signal arising from amides / amines of proteins again confirms the successful detection of viruses with the antibody-coated microsphere.

[0132] Although the viral protein concentration used in the experiment was as high as 0.2 mg / mL, the amount of viral protein passed or interacted with a single microsphere was effectively less than 200-300 fold, as most of them flowed through different parts of the array without any contact with the microsphere. Hence, creating flow patterns on the pillar array was thought to help enrich the viral protein and increase detection efficiency. Furthermore, such patterns could advantageously change the evaporation profile of the liquid inside the micropillar array, thus possibly altering the flow dynamics and the interaction between antibodies and viruses.

[0133] Patterned micropillar arrays as shown in Figure 14(a) were used to operate the same sensing experiments as on an unpatterned array. Table 1 below lists all of the related parameters of the micropillar arrays. The microspheres used for virus detection were located at the neck area of each array sample. In theory, the narrower the neck is, the faster the flow velocity will be, as the evaporation of liquid from the relatively large area need to be refilled from the loading zone through the neck. Meanwhile, a narrow neck will increase the chance of virus interaction with the microsphere.Cross- Total Flow EstimatedEffective sectional sample Time velocity liquid pillar area. area at the volume (min) (pL-min_consumed rate(mm) nec Ik I (mm 22X) / (p iL,) ‘■mm2) (pL-min1-mm2)Pattern 1 27.6 0.021 3.0 15 9.52 0.0072Pattern 2 29.6 0.024 4.5 19 9.87 0.0080Pattern 3 26.8 0.020 3.0 15 10.0 0.0075Unpatterned 44.1 0.050 12.5 35 7.14 0.0081Table 1 - Comparison of the sensing experiments -patterned and unpatterned arrays

[0134] As demonstrated in Figure 14(b), patterned arrays offer a fast sensor response (i.e. , the optical shifts) than the unpatterned. Because of the difference in the effective micropillar area, the amount of virus solution used varied among the patterned / unpatterned samples. In total, 3 pL of virus solution was used for both patterned 1 and 3 samples, 4.5 pL for patterned 2, and 12.5 pL for unpatterned one (Table 1). As all the experiments were performed under the same ambient condition of 23 °C and humidity of 29.5% ± 1.7%, the sample volume consumed over a certain period of time should be proportional to the effective micropillar area.

[0135] As indicated in Table 1 , the estimated liquid consumed rate, which was calculated by dividing total sample volume by time and effective micropillar area, is consistent across all the four samples. The number of viruses interacted with the microsphere, however, tended to depend on the cross-sectional area of the neck, which is believed to be the main reason for the difference in the sensing response. The flow velocity at the neck area where the WGM microsphere was located can also be calculated. Table 1 clearly shows that patterned arrays offer a higher flow velocity than the unpatterned, i.e., a higher number of viruses flowing past the microsphere, increasing the chance of virus binding. Hence, the patterned array renders rapid virus detection more possible.

[0136] This embodiment illustrates a micropillar array integrated optofluidic sensor based on active WGM microsphere resonators for virus detection. The evaporation- driven flow enabled by the micropillar array delivers a very small volume of analytesample to be continuously monitored through the active WGM resonators. The WGM resonators were modified with specific bio-recognition elements to detect the analytes. An optofluidic sensor with a surface modified micropillar array can detect viruses from a 3 pL sample within 15 min of detection time, and it is envisioned that by increasing the sample volume and detection time, a lower detection limit could be achieved with surface modified micropillars in the micropillar array.

[0137] Finally, it is to be understood that other variations and modifications of the matters described above may also fall within the scope of the present invention.

Claims

The claims defining the invention are as follows1. A microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive an analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that analyte solution disperses about a microsphere in the spectral region and the microsphere produces a WGM modulated spectrum suitable for optical spectroscopy.

2. A microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive an analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one functionalized active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that the functionalized active resonator binds an analyte in analyte solution dispersed about a microsphere in the spectral region, which binding is then detected using a WGM modulated spectrum and optical spectroscopy.

3. A microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having:a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive an analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that analyte solution disperses about a microsphere in the spectral region and the microsphere produces a WGM modulated spectrum suitable for optical spectroscopy; and wherein one or more micropillars are surface modified to increase detection sensitivity.

4. A microfluidic device for optical spectroscopy, the device including a base with a planar surface, the planar surface having: a) an array of micropillars projecting from the planar surface forming an open spectral region; and b) a sample loading region configured to receive analyte solution such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region; wherein the micropillars are spaced to form interpillar microchannels, there being at least one functionalized active resonator, in the form of a whispering gallery mode (WGM) microsphere, immobilised between micropillars within a microchannel, such that the functionalized active resonator binds an analyte in analyte solution dispersed about a microsphere in the spectral region, which binding is then detected using a WGM modulated spectrum and optical spectroscopy; and wherein one or more micropillars are surface modified to increase detection sensitivity.

5. A microfluidic device according to any one of claims 1 to 4, wherein sizing of the microspheres is dictated by the spacing between the micropillars.

6. A microfluidic device according to claim 5, wherein the microspheres are immobilised centrally between four adjacent micropillars in a square lattice, with only point contacts with the micropillars.

7. A microfluidic device according to claim 5, wherein the microspheres are immobilised between two adjacent micropillars, with only point contacts with the micropillars.

8. A microfluidic device according to any one of claims 1 to 7, wherein the micropillar array is long enough such that, while the spectral region is inexhausted, there will be a continuous flow of analyte solution.

9. A microfluidic device according to any one of claims 1 to 7, wherein a length of microfluidic device is adopted to allow for a previous liquid sample to be pushed away from microspheres when a new liquid sample is added to the sample loading region, whereby mixing of the previous and new liquid samples is avoided.

10. A microfluidic device according to any one of claims 1 to 7, wherein the micropillar array length is from three millimetres to 100 millimetres.

11. A microfluidic device according to any one of claims 1 to 10, wherein the spectral region is a square, rectangular, circular or oval shape, with a narrowed area either adjacent to the sample loading region or centrally across the spectral region.

12. A microfluidic device according to claim 11 , wherein microspheres are located in the narrowed area.

13. A microfluidic device according to claim 2 or claim 4, wherein microspheres in the spectral region have a functional coating that is able to react, bind or release an analyte to generate or enhance an optical signal.

14. A microfluidic device according to claim 13, wherein the coating comprises any one of a biomolecule, a small molecule, a metal ion or a metal complex formed on the surface of the microspheres to bind a molecule or analyte of interest in the analyte solution.

15. A microfluidic device according to claim 14, wherein the biomolecule is one or more of a protein, a peptide, a lipo-peptide, a protein-binding carbohydrate, a nucleic acid, or a protein-binding ligand.

16. A microfluidic device according to claim 15, wherein the biomolecule is a capture protein or nucleic acid.

17. A microfluidic device according to claim 16, wherein the capture protein is a protein-binding scaffold, streptavidin, a T-cell receptor, a binding-fragment of a TCR, a variable lymphocyte receptor, an antibody and / or a binding-fragment of an antibody18. A microfluidic device according to claim 17, wherein the protein-binding scaffold is selected from the group consisting of: Adnectins, Affilins, Affibodies, Affimer molecules, Affitins, Alphabodies, Aptamers, Anticalins, Armadillo repeat proteinbased scaffolds, Atrimers, Avimers, Designed Ankyrin Repeat Proteins (DARPins), Fynomers, Inhibitor Cystine Knot (ICK) scaffolds, Kunitz Domain peptides, Monobodies and / or Nanofitins.

19. A microfluidic device according to claim 18, wherein the binding-fragment of an antibody includes a Fab, (Fab’)2, Fab’, single-chain variable fragment (scFv), di- and tri- scFvs, single domain antibodies (sdAb), Diabodies or a fusion protein including a binding-domain of an antibody.

20. A microfluidic device according to claim 1 or claim 2, wherein one or more micropillars are surface modified to increase detection sensitivity.

21. A microfluidic device according to any one of claims 1 to 4 and 20, wherein one or more micropillars are surface modified by chemical patterning to create predetermined liquid flow patterns for the analyte solution through the spectral region to increase detection sensitivity.

22. A microfluidic device according to claim 21 , wherein masks are applied to micropillars during or after fabrication of the microfluidic device for chemical patterning.

23. A microfluidic device according to claim 22, wherein the chemical patterning includes applying masks with predetermined patterns onto surfaces of hydrophobised micropillars before exposing the micropillars to oxygen plasma.

24. A microfluidic device according to any one of claims 21 to 23, wherein the creation of flow patterns creates at least two independent micropillar arrays in parallel with each other within one microfluidic device, with each array sharing the same sample loading region.

25. A microfluidic device according to any one of claims 1 to 4 and 20, wherein wherein one or more micropillars are surface modified by reducing interference by undesired chemicals in the analyte solution.

26. A microfluidic device according to claim 25, wherein one or more micropillars are surface modified with charged molecules.

27. A microfluidic device according to any one of claims 20 to 26, wherein the surface modification occurs during the formation of the micropillars, so that the micropillars are directly formed with such surface modifications, or the surface modifications occur as a secondary step after the formation of the micropillars.

28. A microfluidic device according to any one of claims 1 to 27, wherein the micropillar array contains (X-1) microspheres, where X equals the number of micropillars in a single row of micropillars.

29. An optical spectroscopic method of detecting an analyte in a liquid sample, the method including: a) providing a microfluidic device according to any one of claims 1 to 28; b) placing a liquid sample of an analyte solution in the sample loading region of the microfluidic device such that the analyte solution is in fluid contact with micropillars for dispersal of analyte solution from the sample loading region to the spectral region to provide a liquid filled spectral region; c) exposing a first side of the microfluidic device to a light source such that an incident light beam is projected through the liquid in the spectral region to a detector located at a second side of the spectral region that is opposite the first side, or exposing a first side of the microfluidic device to a light sourcesuch that an incident light beam passes through the liquid in the spectral region and is reflected from the base of the microfluidic device to a detector located at the first side of the microfluidic device; and d) measuring at least one parameter of the light at the detector in an optical spectrometer to detect the analyte in the sample.

29. A method according to claim 28, wherein the analyte is a bioanalyte and the liquid sample includes a biological sample from a subject.

30. A method according to claim 29, wherein the bioanalyte is a virus, a protein, a peptide, a nucleic acid, a carbohydrate, a lipo-peptide, a hormone, bacterium, a fungus, a prion, or a fragment of any of the above.

31. Apparatus for optical spectroscopy, the apparatus including the microfluidic device of any one of claims 1 to 28, together with at least a light source and a detector.

32. Apparatus according to claim 31, wherein the detector is an optical spectrometer.